Ramsey R. Hachem
No Rating Available
(Learn About Our Rating System)

Ramsey R. Hachem, MD

Languages spoken: English

Clinical Locations

University of Utah Hospital

Medical Intensive Care Unit
Salt Lake City
801-581-2121

University of Utah Hospital

Pulmonary, Clinic 3
Salt Lake City

  • Ramsey Hachem, MD is an experienced Pulmonary and Critical Care physician who is board certified in Pulmonary Medicine and Critical Care Medicine. His clinical focus is lung transplantation, and he cares for people who are being considered for transplantation or have had a lung transplant. He has an active research program dedicated to understanding and managing rejection after lung transplantation.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

  • Ramsey Hachem, MD is an experienced Pulmonary and Critical Care physician who is board certified in Pulmonary Medicine and Critical Care Medicine. His clinical focus is lung transplantation, and he cares for people who are being considered for transplantation or have had a lung transplant. He has an active research program dedicated to understanding and managing rejection after lung transplantation.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Public Health
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Critical Care Medicine)
    American Board of Internal Medicine (Sub: Pulmonary Disease)

    Education history

    Fellowship Pulmonary and Critical Care Medicine - Washington University School of Medicine Fellow
    Internal Medicine - University of Texas Southwestern Medical Center Intern/Resident
    Professional Medical Medicine - University of Texas Southwestern Medical Center Medical School M.D.
    Chemistry - Southern Methodist University B.A.

    Selected Publications

    Journal Article

    1. Terada Y, Puri V, Meyers BF, Kreisel D, Patterson GA, Hachem RR, Takahashi T (2022). Lung Transplant for Pulmonary Fibrosis With Dendriform Ossification. Ann Thorac Surg, 114(6), e403-e405. (Read full article)
    2. Terada Y, Takahashi T, Hachem RR, Liu J, Witt CA, Byers DE, Guillamet RV, Kulkarni HS, Nava RG, Kozower BD, Meyers BF, Pasque MK, Patterson GA, Kreisel D, Puri V (2022). Clinical features and outcomes of unplanned single lung transplants. J Thorac Cardiovasc Surg, 164(6), 1650-1659.e3. (Read full article)
    3. Yang Z, Takahashi T, Terada Y, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Kulkarni HS, Guillamet RV, Yan Y, Chang SH, Kreisel D, Puri V (2022). A comparison of outcomes after lung transplantation between European and North American centers. J Heart Lung Transplant, 41(12), 1729-1735. (Read full article)
    4. Shepherd HM, Bierhals AJ, Hachem RR, Takahashi T, Pasque MK, Patterson GA, Puri V, Kreisel D, Nava RG (2022). Transplantation of Donor Lung With Partial Anomalous Pulmonary Venous Return Using a Carrel Patch. Ann Thorac Surg, 114(4), e249-e251. (Read full article)
    5. Huang HJ, Schechtman K, Askar M, Bernadt C, Mittler B, Dore P, Witt C, Byers D, Vazquez-Guillamet R, Halverson L, Nava R, Puri V, Gelman A, Kreisel D, Hachem RR (2022). A pilot randomized controlled trial of de novo belatacept-based immunosuppression following anti-thymocyte globulin induction in lung transplantation. Am J Transplant, 22(7), 1884-1892. (Read full article)
    6. Randhawa SK, Yang Z, Morkan DB, Yan Y, Chang SH, Hachem RR, Witt CA, Byers DE, Kulkarni HS, Guillamet RV, Kozower BD, Nava RG, Meyers BF, Patterson GA, Kreisel D, Puri V (2021). One-Year Survival Worse for Lung Retransplants Relative to Primary Lung Transplants. Ann Thorac Surg, 113(4), 1265-1273. (Read full article)
    7. Parkes MD, Halloran K, Hirji A, Pon S, Weinkauf J, Timofte IL, Snell GI, Westall GP, Havlin J, Lischke R, Zajacov A, Hachem R, Kreisel D, Levine D, Kubisa B, Piotrowska M, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Halloran PF (2021). Transcripts associated with chronic lung allograft dysfunction in transbronchial biopsies of lung transplants. Am J Transplant, 22(4), 1054-1072. (Read full article)
    8. Vazquez Guillamet R, Vazquez Guillamet MC, Rjob A, Bierhals A, Bello I, Abularach AJ, Tague L, Wallendorf M, Marklin GF, Witt C, Byers DE, Kreisel D, Nava R, Puri V, Hachem R, Trulock EP (2021). Uncertainty analysis of chest X-ray lung height measurements and size matching for lung transplantation. J Thorac Dis, 14(4), 1042-1051. (Read full article)
    9. Yang Z, Subramanian MP, Yan Y, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Pasque MK, Byers DE, Kulkarni HS, Kreisel D, Itoh A, Puri V (2021). The Impact of Center Volume on Outcomes in Lung Transplantation. Ann Thorac Surg, 113(3), 911-917. (Read full article)
    10. Rahman M, Ravichandran R, Bansal S, Sanborn K, Bowen S, Eschbacher J, Sureshbabu A, Fleming T, Bharat A, Walia R, Hachem R, Bremner RM, Smith MA, Mohanakumar T (2021). Novel role for tumor suppressor gene, liver kinase B1, in epithelial-mesenchymal transition leading to chronic lung allograft dysfunction. Am J Transplant, 22(3), 843-852. (Read full article)
    11. Kapnadak SG, Morrell ED, Wai TH, Goss CH, Shah PD, Merlo CA, Hachem RR, Ramos KJ (2021). Variability in azithromycin practices among lung transplant providers in the International Society for Heart and Lung Transplantation Community. J Heart Lung Transplant, 41(1), 20-23. (Read full article)
    12. Bansal S, Limaye AP, Lee J, Fleming T, Poulson C, Omar A, Hachem R, Bharat A, Bremner RM, Smith MA, Mohanakumar T (2021). Circulating exosomes induced by respiratory viral infections in lung transplant recipients activate cellular stress, innate immune pathways and epithelial to mesenchymal transition. Transpl Immunol, 69, 101480. (Read full article)
    13. Takahashi T, Terada Y, Pasque MK, Liu J, Byers DE, Witt CA, Nava RG, Puri V, Kozower BD, Meyers BF, Kreisel D, Patterson GA, Hachem RR (2021). Clinical Features and Outcomes of Combined Pulmonary Fibrosis and Emphysema After Lung Transplantation. Chest, 160(5), 1743-1750. (Read full article)
    14. Gerull WD, Yang Z, Kreisel D, Nava R, Meyers BF, Patterson GA, Kozower BD, Hachem RR, Witt C, Byers D, Kulkarni H, Guillamet RV, Marklin G, Puri V (2020). Local versus distant lung donor procurement does not influence short-term clinical outcomes. J Thorac Cardiovasc Surg, 162(4), 1284-1293.e4. (Read full article)
    15. Terada Y, Harrison MS, Nava RG, Witt CA, Byers DE, Guillamet RV, Meyers BF, Pasque MK, Patterson GA, Kreisel D, Puri V, Hachem RR, Takahashi T (2021). Incidentally Detected Chronic Lymphocytic Leukemia in Hilar Lymph Nodes at the Time of Lung Transplantation: A Case Report. Transplant Proc, 53(8), 2619-2621. (Read full article)
    16. Tague LK, Bedair B, Witt C, Byers DE, Vazquez-Guillamet R, Kulkarni H, Alexander-Brett J, Nava R, Puri V, Kreisel D, Trulock EP, Gelman A, Hachem RR (2021). Lung protective ventilation based on donor size is associated with a lower risk of severe primary graft dysfunction after lung transplantation. J Heart Lung Transplant, 40(10), 1212-1222. (Read full article)
    17. Yang Z, Gerull WD, Shepherd HM, Marklin GF, Takahashi T, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Pasque MK, Yan Y, Kreisel D, Puri V (2021). Different-team procurements: A potential solution for the unintended consequences of change in lung allocation policy. Am J Transplant, 21(9), 3101-3111. (Read full article)
    18. Terada Y, Gauthier JM, Pasque MK, Takahashi T, Liu J, Nava RG, Hachem RR, Witt CA, Byers DE, Vazquez Guillamet R, Kozower BD, Meyers BF, Aguilar PR, Kulkarni HS, Patterson GA, Kreisel D, Puri V (2020). Clinical Outcomes of Lung Transplants From Donors With Unexpected Pulmonary Embolism. Ann Thorac Surg, 112(2), 387-394. (Read full article)
    19. Yang Z, Takahashi T, Gerull WD, Hamilton C, Subramanian MP, Liu J, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Aguilar PR, Pasque MK, Byers DE, Kulkarni HS, Kreisel D, Puri V (2020). Impact of Nighttime Lung Transplantation on Outcomes and Costs. Ann Thorac Surg, 112(1), 206-213. (Read full article)
    20. Itabashi Y, Ravichandran R, Bansal S, Bharat A, Hachem R, Bremner R, Smith M, Mohanakumar T (2020). Decline in Club Cell Secretory Proteins, Exosomes Induction and Immune Responses to Lung Self-antigens, Kα1 Tubulin and Collagen V, Leading to Chronic Rejection After Human Lung Transplantation. Transplantation, 105(6), 1337-1346. (Read full article)
    21. Frye CC, Gauthier JM, Bery A, Gerull WD, Morkan DB, Liu J, Shea Harrison M, Terada Y, Van Zanden JE, Marklin GF, Pasque MK, Nava RG, Meyers BF, Patterson AG, Kozower BD, Hachem R, Byers D, Witt C, Kulkarni H, Kreisel D, Puri V (2020). Donor management using a specialized donor care facility is associated with higher organ utilization from drug overdose donors. Clin Transplant, 35(3), e14178. (Read full article)
    22. Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, OHalloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE (2021). Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight, 6(4). (Read full article)
    23. Tanaka S, Gauthier JM, Terada Y, Takahashi T, Li W, Hashimoto K, Higashikubo R, Hachem RR, Bharat A, Ritter JH, Nava RG, Puri V, Krupnick AS, Gelman AE, Kreisel D (2020). Bacterial products in donor airways prevent the induction of lung transplant tolerance. Am J Transplant, 21(1), 353-361. (Read full article)
    24. Halloran K, Parkes MD, Timofte I, Snell G, Westall G, Havlin J, Lischke R, Hachem R, Kreisel D, Levine D, Kubisa B, Piotrowska M, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Hirji A, Weinkauf J, Halloran PF (2020). Molecular T-cell‒mediated rejection in transbronchial and mucosal lung transplant biopsies is associated with future risk of graft loss. J Heart Lung Transplant, 39(12), 1327-1337. (Read full article)
    25. Yang Z, Gerull WD, Gauthier JM, Meyers BF, Kozower BD, Patterson GA, Nava RG, Hachem RR, Witt CA, Byers DE, Marklin GF, Ridolfi G, Liu J, Kreisel D, Puri V (2020). Shipping Lungs Greater Distances Increases Costs Without Cutting Waitlist Mortality. Ann Thorac Surg, 110(5), 1691-1697. (Read full article)
    26. Sharma M, Gunasekaran M, Ravichandran R, Fisher CE, Limaye AP, Hu C, McDyer J, Kaza V, Bharat A, Tokman S, Omar A, Arjuna A, Walia R, Bremner RM, Smith MA, Hachem RR, Mohanakumar T (2020). Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: A retrospective analysis. J Heart Lung Transplant, 39(11), 1210-1219. (Read full article)
    27. Gauthier JM, Doyle MBM, Chapman WC, Marklin G, Witt CA, Trulock EP, Byers DE, Hachem RR, Pasque MK, Meyers BF, Patterson GA, Nava RG, Kozower BD, Kreisel D, Chang SH, Puri V (2020). Economic evaluation of the specialized donor care facility for thoracic organ donor management. J Thorac Dis, 12(10), 5709-5717. (Read full article)
    28. Kulkarni HS, Ramphal K, Ma L, Brown M, Oyster M, Speckhart KN, Takahashi T, Byers DE, Porteous MK, Kalman L, Hachem RR, Rushefski M, McPhatter J, Cano M, Kreisel D, Scavuzzo M, Mittler B, Cantu E 3rd, Pilely K, Garred P, Christie JD, Atkinson JP, Gelman AE, Diamond JM (2020). Local complement activation is associated with primary graft dysfunction after lung transplantation. JCI Insight, 5(17). (Read full article)
    29. Bansal S, McGilvrey M, Garcia-Mansfield K, Sharma R, Bremner RM, Smith MA, Hachem R, Pirrotte P, Mohanakumar T (2020). Global Proteomics Analysis of Circulating Extracellular Vesicles Isolated from Lung Transplant Recipients. ACS Omega, 5(24), 14360-14369. (Read full article)
    30. Tanaka S, Gauthier JM, Fuchs A, Li W, Tong AY, Harrison MS, Higashikubo R, Terada Y, Hachem RR, Ruiz-Perez D, Ritter JH, Cella M, Colonna M, Turnbull IR, Krupnick AS, Gelman AE, Kreisel D (2019). IL-22 is required for the induction of bronchus-associated lymphoid tissue in tolerant lung allografts. Am J Transplant, 20(5), 1251-1261. (Read full article)
    31. Nolley E, Fleck J, Kavalieratos D, Dew MA, Dilling D, Colman R, Crespo MM, Goldberg H, Hays S, Hachem R, Lease E, Lee J, Reynolds J, Morrell M, Schenker Y (2020). Lung Transplant Pulmonologists' Views of Specialty Palliative Care for Lung Transplant Recipients. J Palliat Med, 23(5), 619-626. (Read full article)
    32. Kulkarni HS, Tsui K, Sunder S, Ganninger A, Tague LK, Witt CA, Byers DE, Trulock EP, Nava R, Puri V, Kreisel D, Mohanakumar T, Gelman AE, Hachem RR (2019). Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation. Am J Transplant, 20(4), 1028-1038. (Read full article)
    33. Halloran K, Parkes MD, Timofte IL, Snell GI, Westall GP, Hachem R, Kreisel D, Levine D, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Hirji A, Weinkauf J, Halloran PF (2019). Molecular phenotyping of rejection-related changes in mucosal biopsies from lung transplants. Am J Transplant, 20(4), 954-966. (Read full article)
    34. Gunasekaran M, Bansal S, Ravichandran R, Sharma M, Perincheri S, Rodriguez F, Hachem R, Fisher CE, Limaye AP, Omar A, Smith MA, Bremner RM, Mohanakumar T (2020). Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection. J Heart Lung Transplant, 39(4), 379-388. (Read full article)
    35. Tague LK, Byers DE, Hachem R, Kreisel D, Krupnick AS, Kulkarni HS, Chen C, Huang HJ, Gelman A (2019). Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid. Pharmacogenomics J, 20(1), 69-79. (Read full article)
    36. Jacobs MT, Olson M, Ferreira BP, Jin R, Hachem R, Byers D, Witt C, Ghobadi A, DiPersio JF, Pusic I (2019). The use of ruxolitinib for acute graft-versus-host disease developing after solid organ transplantation. Am J Transplant, 20(2), 589-592. (Read full article)
    37. Tague LK, Scozzi D, Wallendorf M, Gage BF, Krupnick AS, Kreisel D, Byers D, Hachem RR, Gelman AE (2019). Lung transplant outcomes are influenced by severity of neutropenia and granulocyte colony-stimulating factor treatment. Am J Transplant, 20(1), 250-261. (Read full article)
    38. Takahashi T, Terada Y, Pasque MK, Itoh A, Nava RG, Puri V, Kreisel D, Patterson AG, Hachem RR (2019). Comparison of outcomes in lung and heart transplant recipients from the same multiorgan donor. Clin Transplant, 34(1), e13768. (Read full article)
    39. January SE, Fester KA, Bain KB, Kulkarni HS, Witt CA, Byers DE, Alexander-Brett J, Trulock EP, Hachem RR (2019). Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction. Clin Transplant, 33(10), e13708. (Read full article)
    40. Puri V, Hachem RR, Frye CC, Harrison MS, Semenkovich TR, Lynch JP, Ridolfi G, Rowe C, Meyers BF, Patterson GA, Kozower BD, Pasque MK, Nava RG, Marklin GF, Brockmeier D, Sweet SC, Chapman WC, Kreisel D (2019). Unintended consequences of changes to lung allocation policy. Am J Transplant, 19(8), 2164-2167. (Read full article)
    41. Tague LK, Witt CA, Byers DE, Yusen RD, Aguilar PR, Kulkarni HS, Bain KB, Fester KA, Puri V, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR (2019). Association between Allosensitization and Waiting List Outcomes among Adult Lung Transplant Candidates in the United States. Ann Am Thorac Soc, 16(7), 846-852. (Read full article)
    42. Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ (2018). Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome. Transplantation, 103(5), 1036-1042. (Read full article)
    43. Scozzi D, Ibrahim M, Liao F, Lin X, Hsiao HM, Hachem R, Tague LK, Ricci A, Kulkarni HS, Huang HJ, Sugimoto S, Krupnick AS, Kreisel D, Gelman AE (2019). Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction. Am J Transplant, 19(5), 1464-1477. (Read full article)
    44. Gauthier JM, Takahashi T, Bierhals AJ, Brody SL, Hachem RR, Witt CA, Byers DE, Yusen RD, Trulock EP, Aguilar PR, Nava RG, Kozower BD, Meyers BF, Patterson GA, Kreisel D, Puri V (2018). Technical Considerations for Lung Transplantation in Kartagener's Syndrome. Ann Thorac Surg, 107(5), e337-e339. (Read full article)
    45. Halloran KM, Parkes MD, Chang J, Timofte IL, Snell GI, Westall GP, Hachem R, Kreisel D, Trulock E, Roux A, Juvet S, Keshavjee S, Jaksch P, Klepetko W, Halloran PF (2019). Molecular assessment of rejection and injury in lung transplant biopsies. J Heart Lung Transplant, 38(5), 504-513. (Read full article)
    46. Liu Z, Liao F, Scozzi D, Furuya Y, Pugh KN, Hachem R, Chen DL, Cano M, Green JM, Krupnick AS, Kreisel D, Perl AKT, Huang HJ, Brody SL, Gelman AE (2019). An obligatory role for club cells in preventing obliterative bronchiolitis in lung transplants. JCI Insight, 5(9). (Read full article)
    47. Elvington M, Liszewski MK, Liszewski AR, Kulkarni HS, Hachem RR, Mohanakumar T, Kim AHJ, Atkinson JP (2019). Development and Optimization of an ELISA to Quantitate C3(H (2) O) as a Marker of Human Disease. Front Immunol, 10, 703. (Read full article)
    48. Gauthier JM, Bierhals AJ, Liu J, Balsara KR, Frederiksen C, Gremminger E, Hachem RR, Witt CA, Trulock EP, Byers DE, Yusen RD, Aguilar PR, Marklin G, Nava RG, Kozower BD, Pasque MK, Meyers BF, Patterson GA, Kreisel D, Puri V (2018). Chest computed tomography imaging improves potential lung donor assessment. J Thorac Cardiovasc Surg, 157(4), 1711-1718.e1. (Read full article)
    49. Takahashi T, Gauthier JM, Albertin EK, Damiano RJ Jr, Patterson GA, Bierhals AJ, Pasque MK, Hachem RR, Puri V, Kreisel D (2018). Transplantation of Lungs Procured From a Donor With an Atrioesophageal Fistula. Ann Thorac Surg, 107(2), e121-e122. (Read full article)
    50. Li W, Gauthier JM, Higashikubo R, Hsiao HM, Tanaka S, Vuong L, Ritter JH, Tong AY, Wong BW, Hachem RR, Puri V, Bharat A, Krupnick AS, Hsieh CS, Baldwin WM 3rd, Kelly FL, Palmer SM, Gelman AE, Kreisel D (2018). Bronchus-associated lymphoid tissue-resident Foxp3+ T lymphocytes prevent antibody-mediated lung rejection. J Clin Invest, 129(2), 556-568. (Read full article)
    51. Roux A, Levine DJ, Zeevi A, Hachem R, Halloran K, Halloran PF, Gibault L, Taupin JL, Neil DAH, Loupy A, Adam BA, Mengel M, Hwang DM, Calabrese F, Berry G, Pavlisko EN (2018). Banff Lung Report: Current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR). Am J Transplant, 19(1), 21-31. (Read full article)
    52. Kulkarni HS, Cherikh WS, Chambers DC, Garcia VC, Hachem RR, Kreisel D, Puri V, Kozower BD, Byers DE, Witt CA, Alexander-Brett J, Aguilar PR, Tague LK, Furuya Y, Patterson GA, Trulock EP 3rd, Yusen RD (2018). Bronchiolitis obliterans syndrome-free survival after lung transplantation: An International Society for Heart and Lung Transplantation Thoracic Transplant Registry analysis. J Heart Lung Transplant, 38(1), 5-16. (Read full article)
    53. Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G (2018). The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments. Transfusion, 58(12), 2933-2941. (Read full article)
    54. Hachem RR, Kamoun M, Budev MM, Askar M, Ahya VN, Lee JC, Levine DJ, Pollack MS, Dhillon GS, Weill D, Schechtman KB, Leard LE, Golden JA, Baxter-Lowe L, Mohanakumar T, Tyan DB, Yusen RD (2018). Human leukocyte antigens antibodies after lung transplantation: Primary results of the HALT study. Am J Transplant, 18(9), 2285-2294. (Read full article)
    55. Balsara KR, Krupnick AS, Bell JM, Khiabani A, Scavuzzo M, Hachem R, Trulock E, Witt C, Byers DE, Yusen R, Meyers B, Kozower B, Patterson GA, Puri V, Kreisel D (2018). A single-center experience of 1500 lung transplant patients. J Thorac Cardiovasc Surg, 156(2), 894-905.e3. (Read full article)
    56. Tambur AR, Campbell P, Claas FH, Feng S, Gebel HM, Jackson AM, Mannon RB, Reed EF, Tinckam K, Askar M, Chandraker A, Chang PP, Colvin M, Demetris AJ, Diamond JM, Dipchand AI, Fairchild RL, Ford ML, Friedewald J, Gill RG, Glotz D, Goldberg H, Hachem R, Knechtle S, Kobashigawa J, Levine DJ, Levitsky J, Mengel M, Milford E, Newell KA, OLeary JG, Palmer S, Randhawa P, Smith J, Snyder L, Starling RC, Sweet S, Taner T, Taylor CJ, Woodle S, Zeevi A, Nickerson P (2018). Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. Am J Transplant, 18(7), 1604-1614. (Read full article)
    57. Chang SH, Kreisel D, Marklin GF, Cook L, Hachem R, Kozower BD, Balsara KR, Bell JM, Frederiksen C, Meyers BF, Patterson GA, Puri V (2018). Lung Focused Resuscitation at a Specialized Donor Care Facility Improves Lung Procurement Rates. Ann Thorac Surg, 105(5), 1531-1536. (Read full article)
    58. Brestoff JR, Vessoni AT, Brenner KA, Uy GL, DiPersio JF, Blinder M, Witt CA, Byers DE, Hachem RR, Truclock EP, Early DS, Anadkat MJ, Musiek A, Javidan-Nejad C, Balfe DM, Rosman IS, Liu C, Zhang L, Despotis GJ, Ruzinova MB, Sehn JK, Amarillo I, Heusel JW, Swat W, Kim BS, Wartman LD, Yusen RD, Batista LFZ (2018). Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation. Thorax, 73(5), 489-492. (Read full article)
    59. Gunasekaran M, Sharma M, Hachem R, Bremner R, Smith MA, Mohanakumar T (2018). Circulating Exosomes with Distinct Properties during Chronic Lung Allograft Rejection. J Immunol, 200(8), 2535-2541. (Read full article)
    60. Aguilar PR, Carpenter D, Ritter J, Yusen RD, Witt CA, Byers DE, Mohanakumar T, Kreisel D, Trulock EP, Hachem RR (2017). The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation. Am J Transplant, 18(4), 936-944. (Read full article)
    61. Aguilar PR, Bemiss BC, Witt C, Byers DE, Kreisel D, Puri V, Meyers B, Patterson GA, Krupnick AS, Yusen RD, Trulock EP, Hachem RR (2017). Impact of Delayed Chest Closure on Surgical Site Infection After Lung Transplantation. Ann Thorac Surg, 104(4), 1208-1214. (Read full article)
    62. Witt CA, Hachem RR (2017). Extracorporeal photopheresis for the management of lung allograft rejection. Clin Transplant, 31(10). (Read full article)
    63. Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Yu J, Hachem R, Gelman AE, Bremner RM, Smith MA, Mohanakumar T (2016). Zbtb7a induction in alveolar macrophages is implicated in anti-HLA-mediated lung allograft rejection. Sci Transl Med, 9(398). (Read full article)
    64. Zou J, Duffy B, Slade M, Young AL, Steward N, Hachem R, Mohanakumar T (2017). Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatch. Hum Immunol, 78(4), 342-349. (Read full article)
    65. Xu Z, Sharma M, Gelman A, Hachem R, Mohanakumar T (2016). Significant role for microRNA-21 affecting toll-like receptor pathway in primary graft dysfunction after human lung transplantation. J Heart Lung Transplant, 36(3), 331-339. (Read full article)
    66. Gunasekaran M, Xu Z, Nayak DK, Sharma M, Hachem R, Walia R, Bremner RM, Smith MA, Mohanakumar T (2016). Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection. Am J Transplant, 17(2), 474-484. (Read full article)
    67. Sofjan AK, Iuppa JA, Bain KB, Deal EN, Witt CA, Hachem RR, Yusen RD (2016). Evaluation of Enoxaparin Dosing as a Risk Factor for Bleeding in Lung Transplant Recipients. Ann Pharmacother, 50(10), 824-31. (Read full article)
    68. Gauthier JM, Hachem RR, Kreisel D (2016). Update on Chronic Lung Allograft Dysfunction. Curr Transplant Rep, 3(3), 185-191. (Read full article)
    69. Nayak DK, Zhou F, Xu M, Huang J, Tsuji M, Hachem R, Mohanakumar T (2016). Long-Term Persistence of Donor Alveolar Macrophages in Human Lung Transplant Recipients That Influences Donor-Specific Immune Responses. Am J Transplant, 16(8), 2300-11. (Read full article)
    70. Thomas L, Hachem R (2016). Bronchiolitis Obliterans Syndrome (BOS) Following Lung Transplant. Am J Respir Crit Care Med, 193(11), P19-20. (Read full article)
    71. Xu Z, Ramachandran S, Gunasekaran M, Nayak D, Benshoff N, Hachem R, Gelman A, Mohanakumar T (2016). B Cell-Activating Transcription Factor Plays a Critical Role in the Pathogenesis of Anti-Major Histocompatibility Complex-Induced Obliterative Airway Disease. Am J Transplant, 16(4), 1173-82. (Read full article)
    72. Chen C, Bain KB, Iuppa JA, Yusen RD, Byers DE, Patterson GA, Trulock EP, Hachem RR, Witt CA (2015). Hyperammonemia Syndrome After Lung Transplantation: A Single Center Experience. Transplantation, 100(3), 678-84. (Read full article)
    73. Kulkarni HS, Bemiss BC, Hachem RR (2015). Antibody-mediated Rejection in Lung Transplantation. Curr Transplant Rep, 2(4), 316-323. (Read full article)
    74. Bosanquet JP, Witt CA, Bemiss BC, Byers DE, Yusen RD, Patterson AG, Kreisel D, Mohanakumar T, Trulock EP, Hachem RR (2015). The impact of pre-transplant allosensitization on outcomes after lung transplantation. J Heart Lung Transplant, 34(11), 1415-22. (Read full article)
    75. Xu Z, Ramachandran S, Gunasekaran M, Zhou F, Trulock E, Kreisel D, Hachem R, Mohanakumar T (2015). MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant, 34(9), 1154-62. (Read full article)
    76. Xu Z, Nayak D, Yang W, Baskaran G, Ramachandran S, Sarma N, Aloush A, Trulock E, Hachem R, Patterson GA, Mohanakumar T (2015). Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA. Am J Transplant, 15(7), 1933-47. (Read full article)
    77. Xu Z, Nayak DK, Benshoff N, Hachem R, Gelman AE, Mohanakumar T (2015). De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class II. J Immunol, 194(12), 6133-43. (Read full article)
    78. Bharat A, Cunningham SA, Scott Budinger GR, Kreisel D, DeWet CJ, Gelman AE, Waites K, Crabb D, Xiao L, Bhorade S, Ambalavanan N, Dilling DF, Lowery EM, Astor T, Hachem R, Krupnick AS, DeCamp MM, Ison MG, Patel R (2015). Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med, 7(284), 284re3. (Read full article)
    79. Ibrahim M, Wang X, Puyo CA, Montecalvo A, Huang HJ, Hachem RR, Andreetti C, Menna C, Chen R, Krupnick AS, Kreisel D, Rendina EA, Gelman AE (2014). Human recombinant apyrase therapy protects against canine pulmonary ischemia-reperfusion injury. J Heart Lung Transplant, 34(2), 247-53. (Read full article)
    80. Hachem RR (2017). Advancing Lung Transplantation. Clin Transpl, 31, 239-247. (Read full article)
    81. Baskaran G, Tiriveedhi V, Ramachandran S, Aloush A, Grossman B, Hachem R, Mohanakumar T (2014). Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients. J Heart Lung Transplant, 33(9), 950-6. (Read full article)
    82. Tiriveedhi V, Banan B, Deepti S, Nataraju A, Hachem R, Trulock E, Alexander PG, Thalachallour M (2013). Role of defensins in the pathogenesis of chronic lung allograft rejection. Hum Immunol, 75(4), 370-7. (Read full article)
    83. Witt CA, Gaut JP, Yusen RD, Byers DE, Iuppa JA, Bennett Bain K, Alexander Patterson G, Mohanakumar T, Trulock EP, Hachem RR (2013). Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant, 32(10), 1034-40. (Read full article)
    84. Seccombe J, Mirza F, Hachem R, Gyawali CP (2013). Esophageal motor disease and reflux patterns in patients with advanced pulmonary disease undergoing lung transplant evaluation. Neurogastroenterol Motil, 25(8), 657-63. (Read full article)
    85. Tiriveedhi V, Gautam B, Sarma NJ, Askar M, Budev M, Aloush A, Hachem R, Trulock E, Myers B, Patterson AG, Mohanakumar T (2013). Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations. J Heart Lung Transplant, 32(8), 807-14. (Read full article)
    86. Mengel M, Campbell P, Gebel H, Randhawa P, Rodriguez ER, Colvin R, Conway J, Hachem R, Halloran PF, Keshavjee S, Nickerson P, Murphey C, OLeary J, Reeve J, Tinckam K, Reed EF (2012). Precision diagnostics in transplantation: from bench to bedside. Am J Transplant, 13(3), 562-8. (Read full article)
    87. Takenaka M, Subramanian V, Tiriveedhi V, Phelan D, Hachem R, Trulock E, Gelman AE, Patterson GA, Hoshinaga K, Mohanakumar T (2012). Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection. J Heart Lung Transplant, 31(11), 1214-22. (Read full article)
    88. Hachem R (2012). Antibody-Mediated Lung Transplant Rejection. Curr Respir Care Rep, 1(3), 157-161. (Read full article)
    89. Hachem RR, Tiriveedhi V, Patterson GA, Aloush A, Trulock EP, Mohanakumar T (2012). Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation. Am J Transplant, 12(8), 2164-71. (Read full article)
    90. Weber J, Tiriveedhi V, Takenaka M, Lu W, Hachem R, Trulock E, Patterson GA, Mohanakumar T (2012). Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17. J Heart Lung Transplant, 31(4), 419-26. (Read full article)
    91. Tiriveedhi V, Angaswamy N, Brand D, Weber J, Gelman AG, Hachem R, Trulock EP, Meyers B, Patterson G, Mohanakumar T (2011). A shift in the collagen V antigenic epitope leads to T helper phenotype switch and immune response to self-antigen leading to chronic lung allograft rejection. Clin Exp Immunol, 167(1), 158-68. (Read full article)
    92. Saini D, Weber J, Ramachandran S, Phelan D, Tiriveedhi V, Liu M, Steward N, Aloush A, Hachem R, Trulock E, Meyers B, Patterson GA, Mohanakumar T (2011). Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts. J Heart Lung Transplant, 30(6), 624-31. (Read full article)
    93. Saini D, Angaswamy N, Tiriveedhi V, Fukami N, Ramachandran S, Hachem R, Trulock E, Meyers B, Patterson A, Mohanakumar T (2010). Synergistic effect of antibodies to human leukocyte antigens and defensins in pathogenesis of bronchiolitis obliterans syndrome after human lung transplantation. J Heart Lung Transplant, 29(12), 1330-6. (Read full article)
    94. Bharat A, Kuo E, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T (2010). Respiratory virus-induced dysregulation of T-regulatory cells leads to chronic rejection. Ann Thorac Surg, 90(5), 1637-44; discussion 1644. (Read full article)
    95. Bharat A, Saini D, Steward N, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T (2010). Antibodies to self-antigens predispose to primary lung allograft dysfunction and chronic rejection. Ann Thorac Surg, 90(4), 1094-101. (Read full article)
    96. Hachem RR, Yusen RD, Meyers BF, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP (2010). Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation. J Heart Lung Transplant, 29(9), 973-80. (Read full article)
    97. Angaswamy N, Saini D, Ramachandran S, Nath DS, Phelan D, Hachem R, Trulock E, Patterson GA, Mohanakumar T (2010). Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation. Hum Immunol, 71(6), 560-5. (Read full article)
    98. Jain R, Hachem RR, Morrell MR, Trulock EP, Chakinala MM, Yusen RD, Huang HJ, Mohanakumar T, Patterson GA, Walter MJ (2010). Azithromycin is associated with increased survival in lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant, 29(5), 531-7. (Read full article)
    99. Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009). The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant, 29(4), 424-31. (Read full article)
    100. Golocheikine A, Nath DS, Basha HI, Saini D, Phelan D, Aloush A, Trulock EP, Hachem RR, Patterson GA, Ahearn JM, Mohanakumar T (2009). Increased erythrocyte C4D is associated with known alloantibody and autoantibody markers of antibody-mediated rejection in human lung transplant recipients. J Heart Lung Transplant, 29(4), 410-6. (Read full article)
    101. Hachem RR, Patterson GA, Trulock EP (2011). Lung transplantation at Barnes-Jewish Hospital and Washington University in St. Louis. Clin Transpl, 227-34. (Read full article)
    102. Puri V, Scavuzzo M, Guthrie T, Hachem R, Krupnick AS, Kreisel D, Patterson GA, Meyers BF (2009). Lung transplantation and donation after cardiac death: a single center experience. Ann Thorac Surg, 88(5), 1609-14; discussion 1614-5. (Read full article)
    103. Agapov E, Battaile JT, Tidwell R, Hachem R, Patterson GA, Pierce RA, Atkinson JJ, Holtzman MJ (2009). Macrophage chitinase 1 stratifies chronic obstructive lung disease. Am J Respir Cell Mol Biol, 41(4), 379-84. (Read full article)
    104. Morrell MR, Patterson GA, Trulock EP, Hachem RR (2008). Acute antibody-mediated rejection after lung transplantation. J Heart Lung Transplant, 28(1), 96-100. (Read full article)
    105. Huang HJ, Yusen RD, Meyers BF, Walter MJ, Mohanakumar T, Patterson GA, Trulock EP, Hachem RR (2008). Late primary graft dysfunction after lung transplantation and bronchiolitis obliterans syndrome. Am J Transplant, 8(11), 2454-62. (Read full article)
    106. Hachem RR, Edwards LB, Yusen RD, Chakinala MM, Alexander Patterson G, Trulock EP (2008). The impact of induction on survival after lung transplantation: an analysis of the International Society for Heart and Lung Transplantation Registry. Clin Transplant, 22(5), 603-8. (Read full article)
    107. Bharat A, Kuo E, Steward N, Aloush A, Hachem R, Trulock EP, Patterson GA, Meyers BF, Mohanakumar T (2008). Immunological link between primary graft dysfunction and chronic lung allograft rejection. Ann Thorac Surg, 86(1), 189-95; discussion 196-7. (Read full article)
    108. Hachem RR, Yusen RD, Chakinala MM, Meyers BF, Lynch JP, Aloush AA, Patterson GA, Trulock EP (2007). A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation. J Heart Lung Transplant, 26(10), 1012-8. (Read full article)
    109. Daud SA, Yusen RD, Meyers BF, Chakinala MM, Walter MJ, Aloush AA, Patterson GA, Trulock EP, Hachem RR (2006). Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med, 175(5), 507-13. (Read full article)
    110. Mikols CL, Yan L, Norris JY, Russell TD, Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Castro M, Kuo E, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ (2006). IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med, 174(4), 461-70. (Read full article)
    111. Hachem RR, Yusen RD, Chakinala MM, Aloush AA, Patterson GA, Trulock EP (2006). Thrombotic microangiopathy after lung transplantation. Transplantation, 81(1), 57-63. (Read full article)
    112. Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, Patterson GA, Trulock EP, Walter MJ (2005). The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation, 80(10), 1406-13. (Read full article)
    113. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB, ISHLT Working Group on Primary Lung Graft Dysfunction (2004). Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: predictors and outcomes. J Heart Lung Transplant, 24(10), 1483-8. (Read full article)
    114. Hachem RR, Chakinala MM, Yusen RD, Lynch JP, Aloush AA, Patterson GA, Trulock EP (2004). A comparison of basiliximab and anti-thymocyte globulin as induction agents after lung transplantation. J Heart Lung Transplant, 24(9), 1320-6. (Read full article)
    115. Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Aloush A, Patterson GA, Mohanakumar T, Trulock EP, Walter MJ (2005). Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant, 5(8), 2022-30. (Read full article)
    116. Chakinala MM, Ritter J, Gage BF, Aloush AA, Hachem RH, Lynch JP, Patterson GA, Trulock EP (2004). Reliability for grading acute rejection and airway inflammation after lung transplantation. J Heart Lung Transplant, 24(6), 652-7. (Read full article)
    117. Khalifah AP, Hachem RR, Chakinala MM, Schechtman KB, Patterson GA, Schuster DP, Mohanakumar T, Trulock EP, Walter MJ (2004). Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med, 170(2), 181-7. (Read full article)
    118. Hachem RR, Chakinala MM, Yusen RD, Lynch JP, Aloush AA, Patterson GA, Trulock EP (2003). The predictive value of bronchiolitis obliterans syndrome stage 0-p. Am J Respir Crit Care Med, 169(4), 468-72. (Read full article)
    119. Hachem RR, Chakinala MM, Yusen RD, Lynch JP, Aloush AA, Patterson GA, Trulock EP (2004). Abdominal-pelvic lymphoproliferative disease after lung transplantation: presentation and outcome. Transplantation, 77(3), 431-7. (Read full article)

    Review

    1. Levine DJ, Hachem RR (2022). Lung Allograft Rejection. [Review]. Thorac Surg Clin, 32(2), 221-229. (Read full article)
    2. Bedair B, Hachem RR (2020). Management of chronic rejection after lung transplantation. [Review]. J Thorac Dis, 13(11), 6645-6653. (Read full article)
    3. Shah P, Lowery E, Chaparro C, Visner G, Hempstead SE, Abraham J, Bhakta Z, Carroll M, Christon L, Danziger-Isakov L, Diamond JM, Lease E, Leonard J, Litvin M, Poole R, Vlahos F, Werchan C, Murray MA, Tallarico E, Faro A, Pilewski JM, Hachem RR (2021). Cystic fibrosis foundation consensus statements for the care of cystic fibrosis lung transplant recipients. [Review]. J Heart Lung Transplant, 40(7), 539-556. (Read full article)
    4. Halverson LP, Hachem RR (2021). Antibody-Mediated Rejection and Lung Transplantation. [Review]. Semin Respir Crit Care Med, 42(3), 428-435. (Read full article)
    5. Hachem RR (2020). Donor-specific antibodies in lung transplantation. [Review]. Curr Opin Organ Transplant, 25(6), 563-567. (Read full article)
    6. Bery AI, Hachem RR (2020). Antibody-mediated rejection after lung transplantation. [Review]. Ann Transl Med, 8(6), 411. (Read full article)
    7. Hachem RR (2019). The role of the immune system in lung transplantation: towards improved long-term results. [Review]. J Thorac Dis, 11(Suppl 14), S1721-S1731. (Read full article)
    8. Ravichandran R, Bansal S, Rahman M, Sharma M, Liu W, Bharat A, Hachem R, Omar A, Smith MA, Mohanakumar T (2019). The role of donor-derived exosomes in lung allograft rejection. [Review]. Hum Immunol, 80(8), 588-594. (Read full article)
    9. Hachem RR (2019). The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches. [Review]. Hum Immunol, 80(8), 583-587. (Read full article)
    10. Gauthier JM, Ruiz-Prez D, Li W, Hachem RR, Puri V, Gelman AE, Kreisel D (2018). Diagnosis, Pathophysiology and Experimental Models of Chronic Lung Allograft Rejection. [Review]. Transplantation, 102(9), 1459-1466. (Read full article)
    11. Hachem R, Corris P (2018). Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome After Lung Transplantation. [Review]. Transplantation, 102(7), 1059-1065. (Read full article)
    12. Hachem RR (2018). Immunosuppression: Have We Learnt Anything? [Review]. Semin Respir Crit Care Med, 39(2), 172-180. (Read full article)
    13. Hachem RR (2017). Acute Rejection and Antibody-Mediated Rejection in Lung Transplantation. [Review]. Clin Chest Med, 38(4), 667-675. (Read full article)
    14. Hachem RR (2016). Humoral responses after lung transplantation. [Review]. Curr Opin Organ Transplant, 21(3), 267-71. (Read full article)
    15. Levine DJ, Glanville AR, Aboyoun C, Belperio J, Benden C, Berry GJ, Hachem R, Hayes D Jr, Neil D, Reinsmoen NL, Snyder LD, Sweet S, Tyan D, Verleden G, Westall G, Yusen RD, Zamora M, Zeevi A (2016). Antibody-mediated rejection of the lung: A consensus report of the International Society for Heart and Lung Transplantation. [Review]. J Heart Lung Transplant, 35(4), 397-406. (Read full article)
    16. Witt CA, Hachem RR (2013). Immunosuppression: what's standard and what's new? [Review]. Semin Respir Crit Care Med, 34(3), 405-13. (Read full article)
    17. Witt CA, Meyers BF, Hachem RR (2012). Pulmonary infections following lung transplantation. [Review]. Thorac Surg Clin, 22(3), 403-12. (Read full article)
    18. Hachem RR (2012). Antibodies to human leukocyte antigens in lung transplantation. [Review]. Clin Transpl, 327-32. (Read full article)
    19. Hachem RR (2009). Lung allograft rejection: diagnosis and management. [Review]. Curr Opin Organ Transplant, 14(5), 477-82. (Read full article)
    20. Lawrence KL, Morrell MR, Storch GA, Hachem RR, Trulock EP (2009). Clinical outcomes of solid organ transplant recipients with ehrlichiosis. [Review]. Transpl Infect Dis, 11(3), 203-10. (Read full article)
    21. Hachem RR, Trulock EP (2008). The new lung allocation system and its impact on waitlist characteristics and post-transplant outcomes. [Review]. Semin Thorac Cardiovasc Surg, 20(2), 139-42. (Read full article)
    22. Hachem RR, Trulock EP (2005). Bronchiolitis obliterans syndrome: pathogenesis and management. [Review]. Semin Thorac Cardiovasc Surg, 16(4), 350-5. (Read full article)

    Editorial

    1. Verleden GM, Glanville AR, Lease ED, Fisher AJ, Calabrese F, Corris PA, Ensor CR, Gottlieb J, Hachem RR, Lama V, Martinu T, Neil DAH, Singer LG, Snell G, Vos R (2019). Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant, 38(5), 493-503. (Read full article)
    2. Glanville AR, Verleden GM, Todd JL, Benden C, Calabrese F, Gottlieb J, Hachem RR, Levine D, Meloni F, Palmer SM, Roman A, Sato M, Singer LG, Tokman S, Verleden SE, von der Thsen J, Vos R, Snell G (2019). Chronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome-A consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant, 38(5), 483-492. (Read full article)
    3. Mulligan MS, Weill D, Davis RD, Christie JD, Farjah F, Singer JP, Hartwig M, Sanchez PG, Kreisel D, Ware LB, Bermudez C, Hachem RR, Weyant MJ, Gries C, Awori Hayanga JW, Griffith BP, Snyder LD, Odim J, Craig JM, Aggarwal NR, Reineck LA (2018). National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation. J Thorac Cardiovasc Surg, 156(6), 2355-2365. (Read full article)
    4. Milross L, Hachem R, Levine D, Glanville AR (2017). Lung autoantibodies: Ready for prime time? J Heart Lung Transplant. (Read full article)
    5. Hachem RR, Reinsmoen NL (2014). What is the definition of a clinically relevant donor HLA-specific antibody (DSA)? Am J Transplant, 15(2), 299-300. (Read full article)
    6. Hachem RR (2008). Thrombotic microangiopathy after lung transplantation: a difficult diagnosis. South Med J, 101(7), 683-4. (Read full article)

    Letter

    1. Bansal S, Tokman S, Fleming T, Maine GN, Sanborn K, Hachem R, Bharat A, Smith MA, Bremner RM, Mohanakumar T (2021). SARS-CoV-2 infection in lung transplant recipients induces circulating exosomes with SARS-CoV-2 spike protein S2. [Letter to the editor]. Clin Transl Med, 11(11), e576. (Read full article)
    2. Xu Z, Ramachandran S, Gunasekaran M, Zhou F, Trulock E, Kreisel D, Hachem R, Mohanakumar T (2016). MicroRNA-144 is unlikely to play a role in bronchiolitis obliterans syndrome. [Letter to the editor]. J Heart Lung Transplant, 35(4), 543-4. (Read full article)